In our research, we found miR-34a down-regulated in cervical cancer tissue and it might be involved in the metastasis and progression in patients with cervical cancer through targeting Bcl2 and c-Met which have been confirmed as targets of miR-34a [40, 41]. The gene discussed is MET; the disease is cervical carcinoma.